Screening for thalassemia: A model of success

Obstetrics and Gynecology Clinics of North America

Volumn 29, Issue 2, 2002, Pages 305-328

  Cao, Antonio ^a   Rosatelli, Maria Cristina ^a   Monni, Giovanni ^b   Galanello, Renzo ^c  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b Osp Regionale per le Microcitemie   (Italy)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

BETA THALASSEMIA; DNA DETERMINATION; GENETIC SCREENING; HUMAN; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW; THALASSEMIA; ENDEMIC DISEASE; FEMALE; GENETIC COUNSELING; GENETICS; HEALTH EDUCATION; HETEROZYGOTE; HETEROZYGOTE DETECTION; INCIDENCE; METHODOLOGY; NUCLEOTIDE SEQUENCE; ORGANIZATION AND MANAGEMENT; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SOUTHERN EUROPE;

BETA-THALASSEMIA; DNA MUTATIONAL ANALYSIS; ENDEMIC DISEASES; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; HEALTH EDUCATION; HETEROZYGOTE; HETEROZYGOTE DETECTION; HUMANS; INCIDENCE; MEDITERRANEAN REGION; PREGNANCY; PRENATAL DIAGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 0036287849     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8545(01)00006-7     Document Type: Review

References (59)

1. Prevention and control of haemoglobinopathies
2. Control of hereditary diseases
3. β-thalassaemia
4. Molecular pathology of thalassemia intermedia
5. Thalassaemia intermedia
6. Phenotype/genotype relationships in monogenic disease: Lessons from the thalassemias
7. Bone marrow transplantation for β-thalassemia
8. Gene therapy for hematopoietic disease
9. Clinical and laboratory features of the α-thalassemia syndrome
10. The β- and δ-thalassemia repository
11. Prenatal diagnosis and screening of the haemoglobinopathies
12. 1993 William Allan award address
13. Molecular analysis of β°-thalassemia intermedia in Sardinia
14. Mild thalassemia: The result of interactions of α and β-thalassemia genes
15. An analysis of fetal hemoglobin variation in sickle cell disease: The relative contribution of the X-linked factor, β-globin haplotypes, α-globin gene number, gender and age
16. Genetic heterogeneity in heterocellular hereditary persistence of fetal hemoglobin
17. Fetal hemoglobin levels in sickle cell disease and normal individuals are partially controlled by an X-linked gene located at Xp22.2
18. Hemoglobin switching
19. A family with segregating triplicated α-globin loci and -thalassemia
20. The triplicated α gene locus and β-thalassaemia
21. Thalassaemia intermedia: Interaction of the triple α-globin gene arrangement and heterozygous β-thalassaemia
22. Molecular basis for dominantly inherited inclusion body β-thalassemia
23. Phenotypic effect of heterozygous α and β°-thalassaemia interaction
24. Hematological phenotype of the double heterozygous state for α and β-thalassemia
25. + thalassemia-Portuguese type: Clinical, haematoligical and molecular studies of a newly defined form of β-thalassaemia
26. 2 β-thalassemia
27. The molecular basis of normal HbA2 (type 2) β-thalassemia in Greece
28. The C-T substitution in the distal CACCC box of the β-globin gene promoter is a common cause of silent β-thalassemia in the Italian population
29. Pitfalls in genetic counselling for β-thalassemia: An individual with 4 different thalassemia mutations
30. Molecular diagnosis and carrier screening for β-thalassemia
31. Current status of thalassemia and the sickle cell syndromes in Greece
32. Chorionic villus sampling and acceptance rate of prenatal diagnosis
33. Genotype of subjects with borderline Hb A2: Implication for β-thalassemia carrier screening
34. DNA-Based Diagnosis of the hemoglobin disorders
35. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS)
36. Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes
37. Identification of the multiple β-thalassemia mutations by denaturing gradient gel electrophoresis
38. Molecular characterisation of β-thalassemia in the Sardinian population
39. Molecular screening and fetal diagnosis of β-thalassemia in the Italian population
40. A β-thalassemia phenotype not linked to the β-globin cluster in an Italian family
41. Detection of numerous Y chromosome bialletic polymorphisms by denaturing high-performance liquid chromatography
42. DNA analysis and diagnostics on oligonucleotide microchips
43. Deletion δ-thalassemia; the 7.2 kb deletion of Corfú δβ-thalassemia in a non-β-thalassaemic chromosome
44. Molecular basis of the δ-thalassemia in cis to hemoglobin Knossos variant
45. A novel δ° mutation in cis with Hb Knossos: A study of different genetic interactions in three Egyptian families
46. Molecular analysis od atypical β-thalassemia heterozygotes
47. Human α-thalassemia syndromes: Detection of molecular defects
48. Successful application of prenatal diagnosis in a pregnancy at risk for homozygous β-thalassemia
49. Polymorphism of DNA sequence in the β-globin gene region: Application to prenatal diagnosis of β-thalassemia in Sardinia
50. Prenatal diagnosis of β-thalassemia. Detection of a single nucleotide mutation in DNA
51. Chorionic villus sampling by rigid forceps: Experience with 300 cases at risk for thalassemia major
52. Prenatal diagnosis of β-thalassemia by second trimester chorionic villus sampling
53. Early transabdominal chorionic villus sampling for couplet at high genetic risk
54. Patient's choice between transcervical and transabdominal chorionic villus sampling
55. Birth of a normal girl after in vitro fertilization and preimplantation diagnosis testing for cystic fibrosis
56. Acceptability of preimplantation diagnosis
57. Isolation of fetal DNA from nucleated erythrocytes in maternal blood
58. Prenatal diagnosis of sickle cell anemia and thalassemia by analysis of fetal cells in maternal blood